Yiyi Biopharmaceutical Development (Shanghai) Co., Ltd.

Founded in 2004, Yiyi Biopharmaceutical Development (Shanghai) Co., Ltd. is a wholly foreign-owned enterprise registered in Zhangjiang High-Tech Park, Pudong, Shanghai. The company is dedicated to the research and development and internationalization of innovative recombinant protein drugs.


Yiyi Biopharmaceutical Development (Shanghai) Co., Ltd., facing the world, uses modern biotechnology and international standards to develop innovative biologics targeting unresolved medical challenges (such as tumors, inflammation, and autoimmune diseases), and simultaneously introduces its products into both domestic and international markets. Our vision is "innovation-driven, making better drugs." Our social responsibility is "enabling more patients to access high-quality biologics."


Since its establishment, the company has developed and established efficient mammalian cell protein expression technology and a complete new drug R&D platform. It has successfully developed multiple innovative biologics at different stages and owns the key manufacturing technologies and domestic and international patents for these products. Genor's unique competitive advantages have attracted professionals with international new drug R&D experience to join. Genor will grow into an enterprise with significant influence in the global modern biopharmaceutical field.

If you would like to learn more about the company, please visit the company's homepage.